Wednesday 29 November 2017

Greater New York Smiles Along With Colgate Bright Smiles, Bright Futures(R) And Baseball Great C.C. Sabathia Raise Oral Health Awareness Among Local Elementary School Children

Free Dental Screenings, Activities, Costumed Characters, and Celebrated Pitcher Help Underscore the Importance of Oral Health at Greater New York Dental Meeting

NEW YORK, Nov. 28, 2017 /PRNewswire/ -- Colgate Bright Smiles, Bright Futures teamed up with professional pitching ace C.C. Sabathia today to educate hundreds of local elementary school children on the importance of maintaining good oral health habits at the Greater New York Dental Meeting's Greater New York Smiles Program at the Jacob K. Javits Convention Center.

Against the backdrop of the largest dental meeting in the United States, Sabathia addressed the students, challenging them to think about oral health as an important part of their overall health and as a healthy habit that could have a major impact on their ability to perform in school and other arenas. The celebrated baseball star also led the students in a rousing cheer that reinforced the importance of healthy habits.

"Your family, teachers, and those of us here today all want you to have a future that you can smile about," Sabathia advised the students. "Listen closely to what you hear this morning, because all of you have the opportunity to be successful, and when you do, a healthy bright smile is going to come in handy."

During their visit to the Greater New York Dental Meeting, the New York City students boarded a Colgate mobile dental van for screenings performed by dental professionals. Volunteers from local hygienist schools staffed brushing stations, teaching the children proper brushing techniques, and oral health-themed videos, games, activity stations, puppets, and costumed characters encouraged the young guests to limit sugar and maintain an effective dental care routine.

Tooth decay is the most common chronic disease of childhood.¹ Left untreated, children with cavities may have difficulty eating, talking, and sleeping.² Oral health disease can also affect a child's attention span, school attendance, and academic performance, leading to significant implications for his or her social development and future success.³ A global oral health education initiative, Colgate Bright Smiles, Bright Futures has been raising oral health awareness among children for more than 25 years. Its fleet of nine mobile dental vans visit more than 1,000 U.S. cities and towns each year, providing free dental screenings, oral health education and treatment referrals, annually reaching nearly 10 million children.

"The importance of encouraging children to play a lead role in taking care of their teeth and gums cannot be overstated," said Dr. Marsha Butler, Vice President, Global Oral Health and Professional Relations, Colgate-Palmolive Company. "Oral health disease can be painful. It can be debilitating, but most important, it can be prevented. Someday soon we're hoping it's a challenge that none of our children have to face."

"The Greater New York Smiles program is a one of a kind program, because it gives back to the community without asking for anything in return," says Dr. Marc B. Gainor, General Chairman, Greater New York Dental Meeting. "It's a chance to offer a unique clinical experience to urban dental and hygiene students while bringing an awareness of dental access issues in NYC to oral healthcare volunteers, teachers and chaperoning parents who travel with the children to the Javits Convention Center."

ABOUT COLGATE-PALMOLIVE
Colgate-Palmolive is a leading global consumer products company, tightly focused on Oral Care, Personal Care, Home Care and Pet Nutrition. Colgate sells its products in over 200 countries and territories around the world under such internationally recognized brand names as Colgate, Palmolive, Speed Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, elmex, Tom's of Maine, Sanex, Ajax, Axion, Fabuloso, Soupline and Suavitel, as well as Hill's Science Diet, Hill's Prescription Diet and Hill's Ideal Balance. For more information about Colgate's global business, visit the Company's web site at http://www.colgatepalmolive.com.

¹ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821841/
² https://www.mchoralhealth.org/PediatricOH/mod1_3.htm
³ https://www.medicaid.gov/medicaid/benefits/downloads/keep-kids-smiling.pdf

SOURCE Colgate-Palmolive Company

CONTACT: Tenley-Ann Hawkins, For Colgate Bright Smiles, Bright Futures, (914) 841-9717, thawks812@msn.com; Colgate-Palmolive Company, Media Relations, (212) 310-2670, Colgate-Palmolive_Media_Inquiry@colpal.com

RELATED LINKS
http://www.colgatepalmolive.com

CytoSorbents to Present at the LD Micro Main Event Investor Conference

MONMOUTH JUNCTION, N.J., Nov. 29, 2017 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using blood purification to prevent or treat life-threatening injury and infection in critically-ill and cardiac surgery patients around the world, will present at the 10^th Annual LD Micro Main Event investor conference held from December 5-7^th, 2017 at the Luxe Sunset Boulevard Hotel in Los Angeles, California. Dr. Phillip Chan, Chief Executive Officer at CytoSorbents, will also participate in one-on-one meetings, made by appointment, with investors who are registered to attend the conference.

Date:	Tuesday, December 5, 2017
Time:	10:30AM PST (1:30PM EST)
Location:	Luxe Sunset Boulevard Hotel, Los Angeles, CA
Webcast:	http://wsw.com/webcast/ldmicro13/ctso/

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. The LD Micro Main Event is the largest independent conference for small/microcap companies and will feature over 200 presenting names. In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and microcap universe. For more information, please visit http://www.ldmicro.com/events.

About CytoSorbents Corporation (NASDAQ: CTSO)

CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb® is approved in the European Union with distribution in 44 countries around the world, as a safe and effective extracorporeal cytokine adsorber, designed to reduce the "cytokine storm" or "cytokine release syndrome" that could otherwise cause massive inflammation, organ failure and death in common critical illnesses such as sepsis, burn injury, trauma, lung injury and pancreatitis, as well as in cancer immunotherapy. These are conditions where the risk of death is extremely high, yet no effective treatments exist. CytoSorb® is also being used during and after cardiac surgery to remove inflammatory mediators, such as cytokines and free hemoglobin, which can lead to post-operative complications, including multiple organ failure. CytoSorbents has completed its REFRESH (REduction in FREe Hemoglobin) 1 trial – a multi-center, randomized controlled study that has demonstrated the safety and efficacy of free hemoglobin reduction with intra-operative CytoSorb® use in a heart-lung machine during complex cardiac surgery. In 2017, the company plans to initiate a pivotal REFRESH 2 trial intended to support U.S. FDA approval. CytoSorb® has been used safely in more than 31,000 human treatments to date.

CytoSorbents' purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Its technologies have received non-dilutive grant, contract, and other funding of approximately $21 million from DARPA, the U.S. Army, the U.S. Department of Health and Human Services, the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), U.S. Special Operations Command (SOCOM) and others. The Company has numerous products under development based upon this unique blood purification technology, protected by 32 issued U.S. patents and multiple applications pending, including CytoSorb-XL™, HemoDefend™, VetResQ™, K⁺ontrol™, ContrastSorb, DrugSorb, and others. For more information, please visit the Company's websites at www.cytosorbents.com and www.cytosorb.com or follow us on Facebook and Twitter.

Forward-Looking Statements

This press release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements about our plans, objectives, representations and contentions and are not historical facts and typically are identified by use of terms such as "may," "should," "could," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential," "continue" and similar words, although some forward-looking statements are expressed differently. You should be aware that the forward-looking statements in this press release represent management's current judgment and expectations, but our actual results, events and performance could differ materially from those in the forward-looking statements. Factors which could cause or contribute to such differences include, but are not limited to, the risks discussed in our Annual Report on Form 10-K, filed with the SEC on March 3, 2017, as updated by the risks reported in our Quarterly Reports on Form 10-Q, and in the press releases and other communications to shareholders issued by us from time to time which attempt to advise interested parties of the risks and factors which may affect our business. We caution you not to place undue reliance upon any such forward-looking statements. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, other than as required under the Federal securities laws.

Please Click to Follow Us on Facebook and Twitter

CytoSorbents Contact:
Amy Vogel
Investor Relations
732-398-5394
avogel@cytosorbents.com

Investor Relations Contact:
Bob Yedid
LifeSci Advisors
646-597-6989
bob@lifesciadvisors.com

Public Relations Contact:
Joshua Berkman
Rubenstein Public Relations
212-805-3055
jberkman@rubensteinpr.com

SOURCE CytoSorbents Corporation

Special Delivery: Domino's(R) Launches Baby Registry

Introducing a baby registry for pizza-loving parents

ANN ARBOR, Mich., Nov. 29, 2017 /PRNewswire/ -- Domino's Pizza (NYSE: DPZ) is preparing for another great delivery. Starting today, the recognized world leader in pizza delivery is sending out birth announcements for its latest labor of love – a baby registry powered by Gugu Guru. Parents-to-be can create their own registry at dominosbabyregistry.com.

"There's nothing more exciting – and exhausting – than welcoming a new member to the family," said Meenakshi Nagarajan, Domino's director of digital marketing. "From baby showers to the big delivery, our baby registry makes it easy to enjoy pizza during the exciting events leading up to the baby's arrival and thereafter."

After creating and customizing their registry, parents can choose from a variety of gift card themes to use before and after their little ones' arrival. For instance, customers can shower expectant moms and dads with the gift of pizza at their gender reveal party, or allow them savor one last bite before baby. All gifts will be delivered to the parents-to-be as Domino's eGift cards.

"Earlier this year we introduced Domino's wedding registry, which was extremely well-received by our customers," said Nagarajan. "Introducing a baby registry was a natural progression. In fact, our baby registry is making its debut exactly nine months later."

One lucky person will win free pizza for a year and several other pizza-themed gifts such as onesies, leggings, moccasins, and mugs from Gugu Guru by entering on their blog or via the widget displayed on the Gugu Guru Facebook page.

Once registrants select their gifts, they can share their wish list with family and friends on social media or with a unique URL.

Know pizza-loving parents who aren't registered? You can still give them a gift! Find more information about Domino's baby registry at dominosbabyregistry.com.

Open to legal residents of USA who are 18 years or older. Void where prohibited or restricted by law. NO PURCHASE NECESSARY TO ENTER OR WIN. A PURCHASE DOES NOT IMPROVE YOUR CHANCES OF WINNING. Ends 12/29/17. To enter and for Official Rules, visit http://blog.guguguru.com/dominos.

About Domino's Pizza^®Founded in 1960, Domino's Pizza is the recognized world leader in pizza delivery, with a significant business in carryout pizza. It ranks among the world's top public restaurant brands with a global enterprise of more than 14,400 stores in over 85 international markets. Domino's had global retail sales of nearly $10.9 billion in 2016, with more than $5.3 billion in the U.S. and more than $5.5 billioninternationally. In the third quarter of 2017, Domino's had global retail sales of more than $2.8 billion, with nearly $1.4 billion in the U.S. and over $1.4 billion internationally. Its system is comprised of independent franchise owners who accounted for over 97% of Domino's stores as of the third quarter of 2017. Emphasis on technology innovation helped Domino's reach an estimated $5.6 billion in global digital sales in 2016, and has produced several innovative ordering platforms, including Google Home, Facebook Messenger, Apple Watch, Amazon Echo, Twitter and text message using a pizza emoji. In late 2017, as part of an industry-first collaboration with Ford Motor Company, Domino's began a meaningful test of delivery using self-driving vehicles.

Order – dominos.com
AnyWare Ordering – anyware.dominos.com
Company Info – biz.dominos.com
Twitter – twitter.com/dominos
Facebook – facebook.com/dominos
Instagram – instagram.com/dominos
YouTube – youtube.com/dominos

Please visit our Investor Relations website at biz.dominos.com to view news, announcements, earnings releases and conference webcasts.

About Gugu Guru
Launched in April of 2015, Gugu Guru is the first and only universal baby registry to deliver free, unbiased and highly personalized product recommendations for expectant and new parents based on their answers to a fun style and lifestyle quiz.

SOURCE Domino's Pizza

CONTACT: Jenny Fouracre, 734-930-3620 (Office), jenny.fouracre@dominos.com

KIND And Mars Announce Partnership To Bring Healthy Snacks And The KIND Promise To People Worldwide

NEW YORK and MCLEAN, Va., Nov. 29, 2017 /PRNewswire/ -- KIND, a healthy snacking leader, and Mars, Incorporated, a family-owned global pet care, confectionery and food business, today announced a strategic partnership whereby Mars will take a minority stake in KIND. As part of the agreement, the two companies will partner to grow KIND's product offerings and business globally, utilizing each other's strengths.

The partnership will allow KIND to continue to drive positive change in the food industry while fulfilling – on a worldwide scale – its KIND Promise, a set of nutrition principles that have guided the company's innovation since its founding. KIND will provide Mars with a pioneering and trusted brand to anchor a newly formed global health and wellness platform, while Mars will provide KIND with its proven international model to expand into new markets. KIND will continue to operate independently, led by its majority stakeholders, founder Daniel Lubetzky and the KIND team, with its existing headquarters in New York, NY. As part of the agreement, Mars will lead the growth of the business outside the U.S. and Canada, partnering with KIND in accordance with the KIND Promise.

The partnership will enable KIND to accelerate its dual mission to make its healthy and tasty foods available to more people across the globe and make the world a little kinder through meaningful social impact initiatives. It will also enable KIND to expand into new categories.

"When we introduced our first whole nut & fruit bar in 2004, we set out on an ambitious mission to do things differently and challenge false compromises by offering snacks that were healthy and tasty as well as wholesome and convenient. It's been exciting to see the reach and impact of our mission, and with our partnership with Mars, we're looking forward to continuing on this journey as we empower more people to make healthy eating decisions across the globe. We remain fully committed to our guiding principles, including our commitment to always use a nutritious food as the first and predominant ingredient in every food product," said Daniel Lubetzky, Founder and CEO of KIND. "We're proud to partner with Mars, a family-owned, principles-driven company with a proven track record of holding a long-term view, and look forward to working with them to make this a better world for future generations."

"This is a partnership built on mutual admiration and a shared vision for growth," said Grant F. Reid, CEO and President of Mars. "We believe there is tremendous opportunity to build on the success of KIND's product portfolio in new markets. As we continue to expand our business and broaden our portfolio to address evolving consumer needs, we're delighted to partner with a respected leader in the health & wellness space."

Every day millions of people do the KIND thing for their bodies by eating KIND's snacks. As KIND continues to expand, it will fulfill its KIND Promise by:

Always using a nutritious food as the first and predominant ingredient in every food product;
Never using artificial sweeteners or sugar alcohols;
Using as little sugar as possible while achieving great taste;
Creating foods that are both healthy and tasty;
Being transparent about everything from ingredients to labeling;
Crafting foods made with minimally processed, real ingredients; and
Treating its foods and people with integrity.

The partnership will also empower KIND to scale its social mission and fulfill its vision to use business as a vehicle for social change. In that spirit, Daniel Lubetzky plans to donate $25 million to The KIND Foundation, a separate philanthropic entity that aims to foster kinder and more empathetic communities.

To learn more, visit www.kindsnacks.com/partnership.

Advisors

BDT & Company and Centerview Partners served as KIND's financial advisors, and Goodwin Procter LLP acted as KIND's legal advisor.

Morgan Stanley & Co. LLC served as Mars' financial advisor, and Simpson Thacher & Bartlett LLP acted as Mars' legal advisor.

About KIND

Since its founding in 2004, KIND® has been on a mission to make the world a little kinder one snack and one act at a time. KIND was born out of its founder's desire to create a snack that was healthy and tasty, wholesome and convenient. What began as a line of premium Fruit & Nut bars sparked the creation of an entirely new healthier snacking category. Today, KIND has a family of snacks that offer solutions for a variety of different occasions.

Its recipes include nutrient-dense, simple and premium ingredients like whole nuts, seeds, whole grains, and pieces of fruit. All of its snacks are gluten free and do not contain genetically engineered ingredients.

Since day one, kindness has been at the core of its business. KIND was founded with a social mission, called the KIND Movement, which celebrates and inspires kindness through acts big and small. Today, the Movement is brought to life through both the brand and The KIND Foundation. To learn more about KIND and to join our Movement, visit kindsnacks.com or follow along on social media @kindsnacks.

About Mars

Mars is a family-owned business with more than a century of history making diverse products and offering services for people and the pets people love. With almost $35 billion in sales, the company is a global business that produces some of the world's best-loved brands: M&M's®, SNICKERS®, TWIX®, MILKY WAY®, DOVE®, PEDIGREE®, ROYAL CANIN®, WHISKAS®, EXTRA®, ORBIT®, 5™, SKITTLES®, UNCLE BEN'S®, MARS DRINKS and COCOAVIA®. Mars also provides veterinary health services that include BANFIELD® Pet Hospitals, Blue Pearl®, VCA® and Pet Partners™. Headquartered in McLean, VA, Mars operates in more than 80 countries. The Mars Five Principles – Quality, Responsibility, Mutuality, Efficiency and Freedom – inspire its more than 100,000 Associates to create value for all its partners and deliver growth they are proud of every day.

For more information about Mars, please visit www.mars.com. Join us on Facebook, Twitter, LinkedIn, Instagram and YouTube.

About The KIND Foundation

The KIND Foundation is a philanthropic entity established by KIND. Its mission, which is to foster kinder and more empathetic communities, is brought to life through a variety of programming meant to celebrate and inspire positive action. The Foundation recently announced a $20 million multi-year initiative called Empatico. An online learning tool that connects kids worldwide and helps them develop skills like curiosity and kindness, Empatico endeavors to reach more than one million students by the end of 2020. To learn more, visit kindsnacks.com/foundation.

SOURCE KIND

CONTACT: Brunswick Group: Jayne Rosefield, 312-800-8120; Blake Sonnenshein, 212-333-3810; KIND: Drew Nannis, 202-236-7016

Atlantis Healthcare Takes Home Gold for Best Persistence/Adherence Program at PM360 Trailblazer Awards

CRANFORD, N.J., Nov. 29, 2017 /PRNewswire/ -- Atlantis Healthcare was named a Trailblazer Gold Award winner for Best Persistence/Adherence program by PM360, a leading trade magazine for the pharmaceutical and biotech industries. The award recognizes outstanding achievement and innovation in healthcare marketing and is shared with Ashfield Healthcare for the Takeda Oncology NINLARO^® (ixazomib) Empower patient support program.

NINLARO Empower is a program from Takeda Oncology that provides personalized education and support for eligible patients who are taking NINLARO as part of their treatment plan. The Empower program leverages health psychology–based motivational and adherence messaging and gives each patient access to an Adherence Clinical Educator (ACE). The Empower ACEs have backgrounds in oncology nursing and have been trained by Atlantis Healthcare in the use of behavior-change techniques to support patients in managing their adherence challenges. The ACEs work to help empower patients with tools to communicate with their healthcare team and educate patients on approaches to manage their treatment schedule. ACEs do not provide medical advice.

"We are honored to collaborate with Ashfield on the development of a personalized education and support program that helps patients manage their treatment and become empowered participants in their care," said Lauren Pugliese, Director, Solutions and Operational Excellence, Atlantis Healthcare. "Our hope is that the success of the Empower program will inspire more companies to create similar programs that provide meaningful support to patients along their treatment journey."

Trailblazer nominations are judged by the PM360 Editorial Advisory Board, a cross-section of industry experts. In addition to recognizing outstanding marketers and companies, the Trailblazer Awards acknowledge healthcare marketing initiatives in 18 distinct categories, including Persistence/Adherence Programs. Gold and silver winners were selected in each category for their ability to stand out in the complex, ever-changing healthcare environment and were judged on content, format, success in reaching targeted audience, and overall quality.

All 68 Trailblazer winners were honored during a special, sold-out reception in New York City and are featured in the October issue of PM360.

About Atlantis Healthcare

Atlantis Healthcare leverages health psychology to develop and deliver uniquely personalized healthcare solutions that drive sustained improvement in treatment adherence and patient self-management across disease states. Led by a team of globally recognized health psychology experts, we use clinically proven models and academic research to develop award-winning behavior change programs worldwide. www.atlantishealthcare.com @AtlantisHlthUS

CONTACT: Fran Kelly, fran.kelly@atlantishealthcare.com

SOURCE Atlantis Healthcare

RxEOB Partners with RxPreferred Benefits Creating New Member Portal

RICHMOND, Va., Nov. 29, 2017 /PRNewswire/ -- RxEOB, an industry leader in supporting member engagement applications for pharmacy benefit management companies, has partnered with pharmacy benefit manager RxPreferred Benefits to create an all-new member portal application.

The app incorporates RxEOB's comprehensive consumer portal MyDrugBenefit® which is designed to help members save on their medication.

"We're always looking to lower costs and deliver a higher quality of care for our members," said Jeff Malone, president and CEO of RxPreferred Benefits. "We've had a lot of demand for pharmacy benefit information. This, combined with RxEOB's experience with pharmacy portal management, made it the right choice to work with RxEOB's team to assist with development, integration and implementation. We know this will help our members for the foreseeable future."

The RxPreferred Benefits portal allows members to find in-network doctors and pharmacies based on location, as well as look up claims and research their most affordable drug options. This grants users the ability to find drug pricing estimates and therapeutic medication options that enable them to save money when purchasing their medications.

"We partnered with RxPreferred Benefits to develop the portal that supports their commercial lives that have their pharmacy claims," said Robert S. Oscar, CEO for RxEOB. "This is in order to help their members get the most out of the benefits their employers' provide. In terms of communicating in today's environment, there is a new expectation that personal transactional and decision support information should be available through a member portal. Patients want to be more engaged in their care, and often the best way to create powerful, personal connections is through a portal to help members prepare for doctor visits and to manage their care."

About RxPreferred Benefits

RxPreferred Benefits is a privately held Pharmacy Benefit Manager founded, and solely owned, by independent pharmacy representatives who understand the importance of what true PBM transparency means.

RxPreferred offers a full line of Pharmacy Benefit Management solutions for employers, hospitals, hospices, brokers and third party administrators. Focused on guaranteed savings and cost-containment strategies, while providing our clients with innovative, efficient, and effective pharmacy benefit management services.

Headquartered in Nashville, Tennessee, RxPreferred is a mission-driven organization, dedicated to outperforming the expectations of our clients, members and shareholders. For more information, visit rxpreferred.com.

About RxEOB

RxEOB's mission is to help PBMs, health plans and TPAs connect with their members through proprietary software applications and effective data management support and analytics. RxEOB's portal, mobile and messaging applications help members access the information they need to save money when using their medical and pharmacy plan benefits and to receive higher quality of care through improved prescription adherence. For more information on how RxEOB can help reduce your overall health care costs, please visit www.rxeob.com, or call 804-643-1540.

MEDIA CONTACT:
Heather Ripley
Ripley PR
865-977-1973
hripley@ripleypr.com

SOURCE RxEOB

Tuesday 28 November 2017

OFIKA GROUP LTD Acquires North West, UK Leading Print Copier Business

MANCHESTER, England, November 29, 2017 /PRNewswire/ --

OFIKA GROUP LTD, the UK's leading Subscription Print Services for desktop multifunction devices, is delighted to announce the acquisition of Pure Copy Ltd in Wigan, Lancashire for an undisclosed sum.

Ryan Singlehurst, CEO of OFIKA said, 'This is a welcomed acquisition for the business and reaffirms our commitment to becoming the leading provider of subscription based print services to the SME market in the UK and overseas. The team at Pure Copy brings a wealth of product and market experience to the business which will allow us to continue to grow our market share within the North West and the UK.'

'With £10m acquisition budget, we'll certainly be looking at making further acquisitions both in the UK and overseas within the coming months.'

Chris Mandley, co-founder of Pure Copy Ltd said, 'We're delighted to now have become part of the mothership which is OFIKA. Pure Copy was a leading print copier supplier to North West businesses, with a solid and reputable client base. We're looking forward to continuing to serve our clients and expanding the range of services open to them under the OFIKA brand.

OFIKA GROUP LTD

OFIKA GROUP LTD is the UK's leading Subscription Print Services company. We're helping thousands of businesses worldwide, save time and money on their desktop multifunction devices (MFD) printing and copying. Subscription print services give businesses the flexibility to cancel their contract in 30-days. There's no finance, no credit checks or maintenance costs and with inclusive hardware all for one monthly subscription payment.

For more information regarding this acquisition, please speak to Chris Brown, Marketing Director at OFIKA GROUP LTD, 3 Hardman Street, 10th floor Spinningfields Manchester M3 3HF, c.brown@ofika.com .

SOURCE OFIKA GROUP LTD

CONTACT: Chris Brown, +44(0)161-240-3607